je.st
news
Meridian Bioscience (VIVO) Expected to Post Q3 2016 Earnings of $0.21 Per Share
2015-11-08 12:51:04| Biotech - Topix.net
Investment analysts at Craig Hallum issued their Q3 2016 earnings per share estimates for shares of Meridian Bioscience in a research note issued on Friday, Zacks Investment Research reports. Craig Hallum analyst B. Bonello forecasts that the firm will earn $0.21 per share for the quarter.
Tags: post
share
expected
vivo
Category:Biotechnology and Pharmaceuticals